Clinical Trials Directory

Trials / Completed

CompletedNCT01109108

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

Streptococcus Pneumonia: Herd Effects and Emergence of Potentially Virulent Serotypes PCV13_Impact of NP Colonization, Herd Effects and Emergence of Potentially Virulent Serotypes of Pneumococci

Status
Completed
Phase
Study type
Observational
Enrollment
9,000 (actual)
Sponsor
Boston Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The specific aim is to evaluate the impact of PCV13 as administered in the pediatric primary care clinic at Boston medical center on the serotype specific carriage of Streptococcus pneumoniae in children \< 5. Specifically the investigators will measure the decline in vaccine serotypes, the proportion of children receiving vaccine required to achieve 50% reduction in serotype specific carriage and the correlation between immunogenicity of the specific serotypes and decline in carriage. The study has been extended to complete 5 years of surveillance to determine the new SP serotype distribution at the time presumably a new equilibrium has been achieved.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2010-04-22
Last updated
2017-03-14
Results posted
2017-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01109108. Inclusion in this directory is not an endorsement.

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage (NCT01109108) · Clinical Trials Directory